[177Lu]Lu-PSMA exhibits accumulation in the lacrimal glands [66], which have been identified as possibly dose-limiting [67], although no significant occurrence of xerophthalmia (dry eyes) has been reported so far. The gene discussed is FOLH1; the disease is Keratoconjunctivitis sicca.